Although CLL and its prognosis are classified by several genetic factors (i.e., ZAP-70 mutation (1), immunoglobulin variable region heavy chain (IGHv) status (2), and β2 microglobulin levels (3)), CLL is not associated with a specific cytogenetic or molecular defect. This evidence concerns the gene HLA-G and B-cell chronic lymphocytic leukemia.